Net Income for Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's current net income (TTM) is $7.71B USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
AMGN
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
$7.71B
YoY change
+88.5%
5Y CAGR
+1.2%
Peak year (2018)
$8.39B
Cumulative net income
$123.07B
Net Income history chart for Amgen (AMGN) from 1985 to 2025
Net Income history table for Amgen (AMGN) from 1985 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | $7.71B | +88.5% | ||
| 2024 | $4.09B | -39.1% | ||
| 2023 | $6.72B | +2.5% | ||
| 2022 | $6.55B | +11.2% | ||
| 2021 | $5.89B | -18.9% | ||
| 2020 | $7.26B | -7.4% | ||
| 2019 | $7.84B | -6.6% | ||
| 2018 | $8.39B | +324.2% | ||
| 2017 | $1.98B | -74.4% | ||
| 2016 | $7.72B | +11.3% | ||
| 2015 | $6.94B | +34.5% | ||
| 2014 | $5.16B | +1.5% | ||
| 2013 | $5.08B | +16.9% | ||
| 2012 | $4.34B | +18.0% | ||
| 2011 | $3.68B | -20.4% | ||
| 2010 | $4.63B | +0.5% | ||
| 2009 | $4.61B | +9.7% | ||
| 2008 | $4.20B | +32.5% | ||
| 2007 | $3.17B | +7.3% | ||
| 2006 | $2.95B | -19.7% | ||
| 2005 | $3.67B | +55.5% | ||
| 2004 | $2.36B | +4.6% | ||
| 2003 | $2.26B | -262.3% | ||
| 2002 | -$1.39B | -224.3% | ||
| 2001 | $1.12B | -1.7% | ||
| 2000 | $1.14B | +3.8% | ||
| 1999 | $1.10B | +27.0% | ||
| 1998 | $863.20M | +34.0% | ||
| 1997 | $644.30M | -5.2% | ||
| 1996 | $679.80M | +26.4% | ||
| 1995 | $537.70M | +68.2% | ||
| 1994 | $319.70M | -16.6% | ||
| 1993 | $383.30M | +7.2% | ||
| 1992 | $357.60M | +265.3% | ||
| 1991 | $97.90M | +412.6% | ||
| 1990 | $19.10M | — | ||
| 1988 | -$8.20M | -582.4% | ||
| 1987 | $1.70M | +112.5% | ||
| 1986 | $800,000 | +60.0% | ||
| 1985 | $500,000 | — |
Net Income values are taken from Amgen's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Amgen (AMGN) net income is $7.71B – surged 88.5% year-over-year.
Over 2020–2025 (5 years), Amgen net income expanded at a +1.2% compound annual rate, with the latest reading among the more recent periods of the dataset.
Between 2018 and 2025, Amgen net income declined 8.1%, falling from $8.39B to $7.71B.
$8.39B stands as the all-time-high annual net income, posted in 2018, against a low of -$1.39B during 2002.
Amgen (AMGN) sits 7th of 8 Healthcare peers we track on this metric, against a peer median of $15.15B.
Amgen Net Income by Year
Amgen Net Income 2025: $7.71B
Amgen net income in 2025 was $7.71B, surged 88.5% from 2024.
Amgen Net Income 2024: $4.09B
Amgen net income in 2024 was $4.09B, plunged 39.1% below 2023.
Amgen Net Income 2023: $6.72B
Amgen net income in 2023 was $6.72B, edged up 2.5% from 2022.
Amgen Net Income 2022: $6.55B
Amgen net income in 2022 was $6.55B, grew 11.2% from 2021.
Amgen Net Income 2021: $5.89B
Amgen net income in 2021 was $5.89B.
See more financial history for Amgen (AMGN).
Sector peers — Net Income
Companies in the same sector as Amgen, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Johnson & Johnson (JNJ) | $26.80B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| AstraZeneca PLC (AZN) | $10.26B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $6.74B | Healthcare |
| AbbVie Inc. (ABBV) | $4.23B | Healthcare |
Frequently asked questions
What is Amgen's net income?
- Latest reported net income for Amgen (AMGN) is $7.71B (period ending December 31, 2025).
How has Amgen net income changed year-over-year?
- Amgen (AMGN) net income changed +88.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Amgen net income?
- Amgen (AMGN) net income compound annual growth rate is +1.2% over the most recent 5 years available.
When did Amgen net income hit its highest annual value?
- Amgen net income reached its highest annual value of $8.39B in 2018.
What was Amgen net income in 2024?
- Amgen (AMGN) net income in 2024 was $4.09B.
What was Amgen net income in 2025?
- Amgen (AMGN) net income in 2025 was $7.71B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AMGN Overview
Company profile, financial tools, and key metrics
AMGN Revenue Counter
Earns $1,166 every second. See per minute, hour, and day.
AMGN Earnings Counter
Earns $244.51 per second net profit. See per minute, hour, and day.
AMGN Economic Scale
Exceeds El Salvador's GDP. Compare with world economies.
AMGN What If Invested
What if you had invested $1,000? See historical returns from any date.
AMGN How It Makes Money
Discover visual breakdown of $36.77B in revenue — where it comes from and where it goes.
AMGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AMGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AMGN Daily Price Character
Balanced · 48.1% historical win rate (green days). Streaks & record days.
AMGN Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
AMGN Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
AMGN Dividend Profile
Yield: 2.86%. Safety: 8/8. See full history.
AMGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AMGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.